Tumor ablation is a minimally invasive treatment that destroys tumors in place, without surgically removing them. A doctor inserts a thin probe directly into the tumor, usually through the skin, and delivers energy (heat, cold, or electrical pulses) that kills the cancer cells while leaving surrounding healthy tissue largely intact. It’s most commonly used for tumors in the liver, kidneys, lungs, and bones, and it can be performed as an outpatient procedure or with a short hospital stay.
How Ablation Destroys Tumor Cells
The core principle is straightforward: deliver enough energy to a tumor that its cells can no longer survive. Depending on the method, this happens through extreme heat, extreme cold, or electrical disruption of cell membranes. Heat-based methods cause cells to burst and proteins to break down, a process called coagulative necrosis. Cold-based methods form ice crystals inside cells that shred them from within. Electrical methods punch permanent holes in cell membranes, causing cells to lose their internal balance and die.
At the edges of the treatment zone, where the energy is less intense, cells often undergo a more orderly form of death called apoptosis, essentially a programmed self-destruct sequence. Doctors deliberately treat a margin of tissue beyond the visible tumor to catch these border cells.
Types of Tumor Ablation
Radiofrequency Ablation (RFA)
RFA is the longest-established thermal method. A needle-like electrode delivers high-frequency electrical current (300 to 500 kHz) into the tumor, causing the surrounding tissue to heat up to roughly 65°C to 90°C. At those temperatures, cells die within minutes. RFA works well for smaller tumors but has a known limitation: blood vessels near the tumor act like a cooling system, carrying heat away before it can do its job. This “heat sink” effect can leave viable tumor cells behind, particularly near large vessels.
Microwave Ablation (MWA)
Microwave ablation heats tissue faster and more uniformly than RFA. Rather than relying on electrical current that spreads outward from the probe, microwaves agitate water molecules directly throughout the tissue. This produces larger treatment zones in less time and is significantly less affected by the heat sink problem. MWA has become increasingly popular for liver and lung tumors for exactly these reasons.
Cryoablation
Cryoablation works in the opposite direction, using extreme cold to kill cells. A probe circulates compressed gas that drops tissue temperatures well below freezing. When cooling is rapid and temperatures fall below minus 40°C, cell death is nearly guaranteed. At slightly warmer subzero temperatures (around minus 20°C to minus 25°C), ice crystals form inside cells during thawing and rupture them from within.
One practical advantage of cryoablation is visibility. The ice ball that forms around the probe shows up clearly on imaging, with its outer edge marking the 0°C boundary. This gives doctors a real-time view of the treatment zone’s size and shape, making it easier to confirm that the entire tumor is covered.
Irreversible Electroporation (IRE)
IRE is fundamentally different from thermal methods. Instead of heat or cold, it delivers rapid, high-voltage electrical pulses lasting only microseconds. These pulses tear permanent holes (nanopores) in cell membranes, causing cells to lose their internal chemical balance and die. Because IRE targets only cell membranes, it spares the structural scaffolding of blood vessels, bile ducts, and nerves. This makes it especially useful for tumors near critical structures that heat or cold would damage. The treated area can regenerate its blood vessel lining afterward, something that isn’t possible when tissue has been cooked or frozen.
How the Procedure Works
Most tumor ablations are performed percutaneously, meaning the probe is inserted through a small skin puncture rather than an open incision. The entire procedure is guided by imaging so the doctor can see exactly where the probe tip sits relative to the tumor.
Ultrasound is the most commonly used guidance tool because it provides real-time feedback without radiation exposure, though it has limited resolution in deeper tissues. CT scanning offers more precise cross-sectional views and is often used for lung and bone tumors. MRI provides the best soft-tissue contrast and can actually measure tissue temperature during the procedure, letting the doctor confirm the tumor is reaching lethal temperatures. In complex cases, doctors combine modalities. PET scan data, for instance, can be fused with CT or ultrasound images to help target tumors that are hard to see on a single imaging type alone.
The procedure itself typically takes 30 minutes to a few hours depending on the tumor’s size, location, and the number of treatment zones needed. Patients receive sedation or general anesthesia.
Recovery and Side Effects
Recovery from percutaneous ablation is considerably faster than from open surgery. Most people experience mild to moderate pain at the treatment site, nausea, and low-grade fever for a few days afterward. This cluster of symptoms, sometimes called post-ablation syndrome, is the body’s inflammatory response to the destroyed tissue and typically resolves within one to two weeks. Many patients return to normal activities within 48 hours, though fatigue may linger longer.
Serious complications are uncommon. Across large studies of liver tumor ablation, major complications occur in roughly 2% to 6% of procedures. These can include bleeding into the abdominal or chest cavity, infection, or, rarely, damage to nearby organs. In a study of over 2,000 liver ablation sessions, the mortality rate was 0.1%. Bleeding requiring intervention occurred in well under 1% of cases, and bowel perforation was essentially zero.
How Ablation Compares to Surgery
For small tumors, particularly early-stage liver cancers, ablation and surgical removal produce similar long-term survival. Meta-analyses comparing percutaneous radiofrequency ablation to surgical approaches for liver cancer found no significant difference in overall survival at one, three, or five years. Local recurrence rates were also comparable, hovering around 19% to 21% regardless of approach.
Where surgery still holds an edge is in disease-free survival over longer time horizons, meaning patients who undergo surgery may go longer before any cancer returns somewhere in the body. This difference likely reflects the fact that surgery removes a wider margin of tissue. For patients who are good surgical candidates with larger or more complex tumors, surgery remains the standard. But for patients who can’t tolerate surgery due to age, other health conditions, or tumor location, ablation offers a treatment with real curative potential and far less physical stress.
Which Tumors Are Treated With Ablation
Liver tumors are the most common target, including both primary liver cancer and metastases from colorectal and other cancers. Kidney tumors under 4 centimeters are frequently treated with ablation as a first-line option, particularly in older patients or those with a single kidney. Lung tumors that are small and peripheral respond well to both RFA and microwave ablation. Bone metastases are treated primarily for pain relief rather than cure, and cryoablation is often preferred in this setting because the ice ball boundary is easy to monitor near sensitive structures like nerves.
The general sweet spot for ablation is tumors under 3 to 5 centimeters. Larger tumors require overlapping treatment zones, which increases procedure time, complexity, and the chance of incomplete treatment. For tumors above that size range, ablation is sometimes combined with other therapies like chemoembolization or systemic treatment rather than used alone.